Search - tctmd.com

Displaying 861 - 880 of 1929

Sort: Relevancy | Date

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

Presentation TCT Abstracts Posters 2018

Evaluation of Cerebrovascular Events in Patients with Malignancy versus Patients without Malignancy Undergoing Transcatheter Aortic Valve Replacement

Presenter: Christopher Bitetzakis

September 25, 2018

Presentation TCT Abstracts Posters 2018

Permanent Pacemaker Implantation in Patients with Pre-existing Right Bundle Branch Block undergoing Transcatheter Aortic Valve Replacement

Presenter: Lohit Garg

September 25, 2018

Presentation TCT Abstracts Posters 2018

Clinical Outcomes for Transcatheter Aortic Valve Replacement at Veterans Health Administration Hospitals

Presenter: Lucas Burke

September 25, 2018

Presentation TCT Abstracts Posters 2018

Clinical Outcomes for Transcatheter Aortic Valve Replacement at Veterans Health Administration Hospitals

Presenter: Lucas Burke

September 25, 2018

Presentation TCT Abstracts Posters 2018

Admission for Decompensated Congestive Heart Failure Within 30 days Prior to Transcatheter Aortic Valve Replacement is Associated with High Rates of Mortality and Readmission Within

Presenter: Tariq Bhat

September 25, 2018

Presentation TCT Abstracts Posters 2018

Short and long term prognostic value of new onset LBBB post Transcatheter Aortic Valve Replacement

Presenter: George M. Yousef

September 25, 2018

Presentation TCT 2018

Case 1 (A): Left Main Stem (LMS Percutaneous Coronary Intervention (PCI) With High Speed Rotational Atherectomy (HSRA) Prior To Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Wojtek Wojakowski, Mirvat Alasnag, Ori Ben-Yehuda, Carlos Cabrera Arroyo, Rabin dra Nath Chakraborty, Mohamed Ahmed Sobhy, Pedro de Araujo Goncalves

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

OBSERVANT: Five-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in a Low/Intermediate-Risk Real-world Population

Presenter: Horst Sievert, Brian K. Whisenant, Marco Barbanti

September 23, 2018

Presentation TCT 2018

SURTAVI: Two-Year Complete Results From a Randomized Trial of a Self-Expanding Transcatheter Heart Valve vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk

Presenter: Horst Sievert, Brian K. Whisenant, Jeffrey J. Popma

September 23, 2018

Presentation TCT 2018

Prosthesis-Patient Mismatch: Incidence, Predictors, and Outcome of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement

Presenter: Valentin Fuster, Howard C. Herrmann

September 23, 2018

Presentation TCT 2018

Opinion Patient Preferences and Shared Decision-Making Requires Open Access to Both TAVR and SAVR

Presenter: Megan Coylewright

September 22, 2018

Presentation TCT 2018

Counterpoint SAVR Is the Gold Standard and Deserves Priority Treatment!

Presenter: Alfredo Trento

September 22, 2018

Presentation TCT 2018

Point Parity Should Include Valve Assessments, Regulatory Standards, and Equal Patient Access

Presenter: Michael J. Mack

September 22, 2018

Presentation TCT 2018

Opinion Tiered Systems of Care Are Preferred to Optimize Patient Care In Valvular Heart Disease

Presenter: Patrick T. O'Gara

September 22, 2018

Presentation TCT 2018

Counterpoint Volume Thresholds Distort Clinical Practice, Quality Metrics are the Priority and Have a Greater Impact on Outcomes

Presenter: Martin B. Leon

September 22, 2018

Presentation TCT 2018

Point Volume Threshold Increases are Needed to Assess Quality and Improve Clinical Outcomes

Presenter: Joseph E. Bavaria

September 22, 2018

Presentation TCT 2018

Opinion Concerns of TAVR Access for Underserved Populations

Presenter: Aaron Horne, Jr.

September 22, 2018

Presentation TCT 2018

Counterpoint Current and Future Demands Will Require TAVR Site Expansion

Presenter: Mark J. Russo

September 22, 2018

Advertisement

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Evaluation of Cerebrovascular Events in Patients with Malignancy versus Patients without Malignancy Undergoing Transcatheter Aortic Valve Replacement

Permanent Pacemaker Implantation in Patients with Pre-existing Right Bundle Branch Block undergoing Transcatheter Aortic Valve Replacement

Clinical Outcomes for Transcatheter Aortic Valve Replacement at Veterans Health Administration Hospitals

Clinical Outcomes for Transcatheter Aortic Valve Replacement at Veterans Health Administration Hospitals

Admission for Decompensated Congestive Heart Failure Within 30 days Prior to Transcatheter Aortic Valve Replacement is Associated with High Rates of Mortality and Readmission Within

Short and long term prognostic value of new onset LBBB post Transcatheter Aortic Valve Replacement

Case 1 (A): Left Main Stem (LMS Percutaneous Coronary Intervention (PCI) With High Speed Rotational Atherectomy (HSRA) Prior To Transcatheter Aortic Valve Replacement (TAVR)

High Mortality but Durable Results With Valve-in-Valve TAVR

OBSERVANT: Five-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in a Low/Intermediate-Risk Real-world Population

SURTAVI: Two-Year Complete Results From a Randomized Trial of a Self-Expanding Transcatheter Heart Valve vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk

Prosthesis-Patient Mismatch: Incidence, Predictors, and Outcome of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement

Opinion Patient Preferences and Shared Decision-Making Requires Open Access to Both TAVR and SAVR

Counterpoint SAVR Is the Gold Standard and Deserves Priority Treatment!

Point Parity Should Include Valve Assessments, Regulatory Standards, and Equal Patient Access

Opinion Tiered Systems of Care Are Preferred to Optimize Patient Care In Valvular Heart Disease

Counterpoint Volume Thresholds Distort Clinical Practice, Quality Metrics are the Priority and Have a Greater Impact on Outcomes

Point Volume Threshold Increases are Needed to Assess Quality and Improve Clinical Outcomes

Opinion Concerns of TAVR Access for Underserved Populations

Counterpoint Current and Future Demands Will Require TAVR Site Expansion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content